- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.03. | Catheter Precision secures up to $88M in strategic financing | 2 | Seeking Alpha | ||
| 11.03. | Catheter Precision, Inc. Secures up to $88 Million in Strategic Institutional Financing Commitments to Fund Accelerated Growth | 153 | GlobeNewswire (Europe) | FORT MILL, S.C., March 11, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) today announced transformational balance sheet improvements through new institutional capital commitments... ► Artikel lesen | |
| 10.03. | Catheter Precision Jumps On Acquiring Fly Flyte From Creatd | - | RTTNews | ||
| 10.03. | Creatd sells remaining stake in Fly Flyte to Catheter Precision for about $12 mln in cash and equity | 1 | Seeking Alpha | ||
| 09.03. | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 06.03. | Catheter Precision, Inc.: Catheter Precision's LockeT Suture Retention Device to be Featured in Live Cases at ISLAA 2026 | 1 | GlobeNewswire (USA) | ||
| 19.02. | Catheter Precision to sell atherectomy catheter assets, focus on electrophysiology | 1 | MassDevice | ||
| CATHETER PRECISION Aktie jetzt für 0€ handeln | |||||
| 19.02. | Catheter Precision Divests Non-Core Assets As It Shifts Focus | 1 | Benzinga.com | ||
| 19.02. | Catheter Precision, Inc.: Catheter Precision Announces Strategic Sale of Non-Core Assets to Strengthen Balance Sheet and Accelerate Electrophysiology Growth | 807 | GlobeNewswire (Europe) | FORT MILL, S.C., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a leader in advanced electrophysiology solutions, today announced it has entered into a definitive... ► Artikel lesen | |
| 17.02. | Catheter Precision acquires 20% stake in Creatd's aviation subsidiary | 1 | Investing.com | ||
| 17.02. | Catheter Precision steigt mit 20 % bei Luftfahrt-Tochter von Creatd ein | 2 | Investing.com Deutsch | ||
| 17.02. | CREATD INC.: VTAK Acquires 20% Interest in Creatd's Subsidiary Fly Flyte, Inc. | 93 | GlobeNewswire (Europe) | Strategic Partnership: Creatd expanded Fly Flyte's investor network by adding NYSE-listed VTAK as an investor in its subsidiary.Portfolio Expansion: Creatd continues advancing its portfolio strategy... ► Artikel lesen | |
| 17.02. | Catheter Precision, Inc.: VTAK Acquires 19.98% Strategic Stake in AI-Enabled Aviation Company Fly Flyte, Inc. | 235 | GlobeNewswire (Europe) | Immediate Exposure to Revenue-Generating, Asset-Backed Regional Air Mobility Business Positioned Ahead of Anticipated Future Industry-wide eVTOL Commercialization Strategic Investment Expands Capital... ► Artikel lesen | |
| 12.02. | Catheter Precision, Inc. Secures up to $36.5 Million in Strategic Institutional Financing to Accelerate Growth | 1 | GlobeNewswire (USA) | ||
| 06.02. | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 22.01. | Catheter Precision, Inc.: Catheter Precision Receives First Purchase Order for LockeT in Germany | 801 | GlobeNewswire (Europe) | FORT MILL, S.C., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the... ► Artikel lesen | |
| 20.01. | Catheter Precision, Inc.: Catheter Precision Received new VIVO Purchase Order from Leading Hospital in Slovenia | 4 | GlobeNewswire (USA) | ||
| 25.11.25 | Catheter Precision, Inc.: Historic Win for Electrophysiology Reimbursement in Ambulatory Surgery Centers Provides Unique Opportunity for Catheter Precision's LockeT Device | 1.003 | GlobeNewswire (Europe) | FORT MILL, S.C., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the... ► Artikel lesen | |
| 21.11.25 | Catheter Precision, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 14.11.25 | Catheter Precision, Inc. - 8-K, Current Report | - | SEC Filings |
1 2 Weiter >>
38 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 43,690 | -1,82 % | EQS-DD: Fresenius SE & Co. KGaA: Sara Hennicken, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
16.03.2026 / 17:10... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,740 | -1,38 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| ECKERT & ZIEGLER | 13,750 | -2,62 % | EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Eckert & Ziegler SE
Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective... ► Artikel lesen | |
| BICO GROUP | 1,530 | -0,26 % | BICO Group AB: BICO Group AB has divested the Finnish property for a total of EUR 3.5m | BICO Group AB ("BICO") has completed the divestment of its property in Oulu, Finland, through the sale of BICO Real Estate Oy to Logistea AB ("Logistea"). The total sales price amounts to EUR 3.5m,... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,098 | -0,51 % | Sernova Biotherapeutics Inc: Sernova says Swetlow fired over trip, improper payouts | ||
| CARDINAL HEALTH | 179,45 | -0,22 % | Cardinal Health report highlights cost savings and provider confidence in biosimilars | New analysis shows biosimilars are projected to strengthen cost savings and provider confidence across the healthcare ecosystem, with oncology leading in adoption... ► Artikel lesen | |
| RESMED | 194,50 | -0,56 % | With global populations ageing, are ResMed shares a good buy today? | ||
| ATOSSA THERAPEUTICS | 0,001 | -100,00 % | Atossa Therapeutics Inc: Atossa Therapeutics Strengthens Clinical Leadership Team with the Addition of Two Experienced Biopharma Executives | Kathy Puyana Theall, M.D. and Adebola Giwa, M.D. bring deep expertise across oncology, rare diseases, and global clinical development to support advancement of Atossa's... ► Artikel lesen | |
| ZIMMER BIOMET | 76,18 | +0,37 % | How Is Zimmer Biomet Holdings' Stock Performance Compared to Other Medical Devices Stocks? | ||
| UNIDOC HEALTH | 0,075 | +6,24 % | UniDoc stellt Installation des H3 Health Cube in Italien fertig | - Der KI-gestützte Health Cube steht
ab sofort den Patienten im Dorf Guardia Perticara in der italienischen Region Basilikata zur Verfügung.
VANCOUVER, British Columbia... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin | BOULDER, CO / ACCESS Newswire / March 18, 2026 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn technology based stabilized hypochlorous... ► Artikel lesen | |
| CO-DIAGNOSTICS | 2,550 | -3,41 % | Co-Diagnostics expands South Asia distribution territory | ||
| CYTOSORBENTS | 0,563 | -0,71 % | Cytosorbents Corp: CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update | Fourth quarter and Full-Year 2025 revenue are expected to be approximately $9.2 million and $37.0 million, respectively, with expected Q4 gross margins in the range... ► Artikel lesen | |
| VERU | 2,240 | -2,18 % | Veru Inc.: Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss | -- The Phase 2b study to assess enobosarm's ability to preserve lean mass, physical function, and bone as well as burn more fat to produce greater quality and quantity of weight loss in older patients... ► Artikel lesen | |
| CLARIANE | 3,630 | +0,89 % | Korian Stiftungsaward 2026 geht an "Rollstuhl-Erlebnisreisen GIAMBO gUG"- innovative Reisen für Menschen mit Assistenzbedarf | München (ots) - Der diesjährige Korian Stiftungsaward für Vielfalt und Respekt in der Pflege geht an die Rollstuhl-Erlebnisreisen GIAMBO gUG aus Hamburg. Die Korian Stiftung für Pflege und würdevolles... ► Artikel lesen |
CATHETER PRECISION INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -5,79 % bei einem Aktienkurs von 1,220 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CATHETER PRECISION INC finden Sie auf Wallstreet Online.